G-quadruplex DNA Targeted Metal Complexes Acting As Potential Anticancer Drugs

Qian Cao,Yi Li,E. Freisinger,Peter Z. Qin,Roland K. O. Sigel,Zong‐Wan Mao

DOI: https://doi.org/10.1039/c6qi00300a

IF: 7.779

2017-01-01

Inorganic Chemistry Frontiers

Abstract:This review summarizes the recent development of G4 DNA targeted metal complexes and discusses their potential as anticancer drugs.

What problem does this paper attempt to address?

G-quadruplex ligands in cancer therapy: Progress, challenges, and clinical perspectives

Joana Figueiredo,Jean-Louis Mergny,Carla Cruz

DOI: https://doi.org/10.1016/j.lfs.2024.122481

IF: 6.78

2024-02-01

Life Sciences

Abstract:Guanine-rich sequences can form G-quadruplexes (G4) in living cells, making these structures promising anti-cancer targets. Compounds able to recognize these structures have been investigated as potential anticancer drugs; however, no G4 binder has yet been approved in the clinic. Here, we describe G4 ligands structure-activity relationships, in vivo effects as well as clinical trials. Addressing G4 ligand characteristics, targeting challenges and structure-activity relationships, this review provides insights into the development of potent and selective G4-targeting molecules for therapeutic applications.

pharmacology & pharmacy,medicine, research & experimental
Interaction of Metal Complexes with G-quadruplex

SUN Jing,CHEN Jia-xi,CHEN Huo-yan,MAO Zong-wan

DOI: https://doi.org/10.3969/j.issn.1001-1978.2012.04.007

2012-01-01

Abstract:The activity of telomerase can be prohibited by the secondary structure of the telomere DNA-G-quadruplex formed by the single chain in G-rich field,resulting in the apoptosis in tumor cells.Compound which can induce the formation or stabilize the structure of G-quadruplex might be potential anticancer drug.The relative ease of synthesis,the variable structure and the positively charged center enable the metal complexes to interact with the grooves and loops of the quadruplex and negatively charged phosphates backbone.Therefore,many metal complexes have been designed and synthesized.This paper reviews the discoveries in the interaction of G-quadruplex with metal complexes in the past years.
Design of Selective G-quadruplex Ligands As Potential Anticancer Agents

Jia‐Heng Tan,Lian‐Quan Gu,Jian-Yong Wu

DOI: https://doi.org/10.2174/138955708785909880

2008-01-01

Abstract:G-quadruplex structures are promising targets for design of cancer drugs with high selectivity and low toxicity. This review provides an update of the progress made over the last few years in the design of selective G-quadruplex ligands, and a comprehensive summary of the major design strategies and structural characteristics. Keywords: G-quadruplex, G-quartet, ligands, substituted derivatives, affinity and selectivity, DNA interactions, telomerase inhibition
G-quadruplexes: targets in anticancer drug design.

Tian-miao Ou,Yu-jing Lu,Jia-heng Tan,Zhi-shu Huang,Kwok-yin Wong,Lian-quan Gu

DOI: https://doi.org/10.1002/cmdc.200700300

IF: 3.54

2008-01-01

ChemMedChem

Abstract:G-quadruplexes ore special secondary structures adopted in some guanine-rich DNA sequences. As guanine-rich sequences are present in important regions of the eukoryotic genome, such as telomeres and the regulatory regions of many genes, such structures may play important roles in the regulation of biological events in the body. G-quadruplexes have become valid targets for new anticancer drugs in the post few decades. Many leading compounds that target these structures have been reported, and a few of them hove entered preclinical or clinical trials. Nonetheless, the electivity of this kind of antitumor compound has yet to be improved in order to suppress the side effects caused by nonselective binding. As drug design targets, the topology and structural characteristics of quadruplexes, their possible biological roles, and the modes and sites of small-ligand binding to these structures should be understood clearly. Herein we provide a summary of published research that has set out to address the above problem to provide useful information on the design of small ligands that target G-quadruplexes. This review also covers research methodologies that have been developed to study the binding of ligands to G-quadruplexes.
G-Quadruplex-Guided Cisplatin Triggers Multiple Pathways in Targeted Chemotherapy and Immunotherapy

Tian-Zhu Ma,Liu-Yi Liu,You-Liang Zeng,Ke Ding,Hang Zhang,Wenting Liu,Qian Cao,Wei Xia,Xushen Xiong,Chao Wu,Zong-Wan Mao

DOI: https://doi.org/10.1039/d4sc00643g

IF: 8.4

2024-05-16

Chemical Science

Abstract:G-quadruplexes (G4s) are atypical nucleic acid structures involved in basic human biological processes and are regulated by small molecules. To date, pyridostatin and its derivatives [e.g., PyPDS (4-(2-aminoethoxy)-N2, N6-bis(4-(2-(pyrrolidin-1-yl) ethoxy) quinolin-2-yl) pyridine-2,6-dicarboxamide)] are the most widely used G4-binding small molecules and considered to have the best G4 specificity, which provides a new option for the development of cisplatin-binding DNA. By combining PyPDS with cisplatin and its analogs, we synthesize three platinum complexes, named PyPDSplatins. We found that cisplatin with PyPDS (CP) exhibit stronger specificity for covalent binding to G4 domains even in the presence of large amounts of dsDNA compared with PyPDS either extracellularly or intracellularly. Multiomics analysis reveal that CP can effectively regulate G4 functions, directly damage G4 structures, activate multiple antitumor signaling pathways, including typical cGAS-STING pathway and AIM2-ASC pathway, trigger a strong immune response and lead to potent antitumor effects. These findings reflect that cisplatin-conjugated specific G4 targeting groups have antitumor mechanisms different from those of classic cisplatin and provide new strategies for the antitumor immunity of metals.

chemistry, multidisciplinary
G-quadruplex stabilization via small-molecules as a potential anti-cancer strategy

Annoor Awadasseid,Xudong Ma,Yanling Wu,Wen Zhang

DOI: https://doi.org/10.1016/j.biopha.2021.111550

2021-07-01

Abstract:<p>G-quadruplexes (G4) are secondary four-stranded DNA helical structures consisting of guanine-rich nucleic acids, which can be formed in the promoter regions of several genes under proper conditions. Several cancer cells have been shown to emerge from genomic changes in the expression of crucial growth-regulating genes that allow cells to develop and begin to propagate in an undifferentiated state. Recent attempts have focused on producing treatments targeted at particular protein products of genes that are abnormally expressed. Many of the proteins found are hard to target and considered undruggable due to structural challenges, protein overexpression, or mutations that affect treatment resistance. The utilization of small molecules that stabilize secondary DNA structures existing in several possible oncogenes' promoters and modulate their transcription is a new strategy that avoids some of these problems. In this review, we outline the function of G-quadruplex stabilization in cancer by small-molecules with the aim to improve cancer therapy.</p>

pharmacology & pharmacy,medicine, research & experimental
G-quadruplexes: a promising target for cancer therapy

Nils Kosiol,Stefan Juranek,Peter Brossart,Annkristin Heine,Katrin Paeschke

DOI: https://doi.org/10.1186/s12943-021-01328-4

IF: 37.3

2021-02-25

Molecular Cancer

Abstract:Abstract DNA and RNA can fold into a variety of alternative conformations. In recent years, a particular nucleic acid structure was discussed to play a role in malignant transformation and cancer development. This structure is called a G-quadruplex (G4). G4 structure formation can drive genome instability by creating mutations, deletions and stimulating recombination events. The importance of G4 structures in the characterization of malignant cells was currently demonstrated in breast cancer samples. In this analysis a correlation between G4 structure formation and an increased intratumor heterogeneity was identified. This suggests that G4 structures might allow breast cancer stratification and supports the identification of new personalized treatment options. Because of the stability of G4 structures and their presence within most human oncogenic promoters and at telomeres, G4 structures are currently tested as a therapeutic target to downregulate transcription or to block telomere elongation in cancer cells. To date, different chemical molecules (G4 ligands) have been developed that aim to target G4 structures. In this review we discuss and compare G4 function and relevance for therapeutic approaches and their impact on cancer development for three cancer entities, which differ significantly in their amount and type of mutations: pancreatic cancer, leukemia and malignant melanoma. G4 structures might present a promising new strategy to individually target tumor cells and could support personalized treatment approaches in the future.

oncology,biochemistry & molecular biology
Targeting G-quadruplex nucleic acids with heterocyclic alkaloids and their derivatives.

Yun-Xia Xiong,Zhi-Shu Huang,Jia-Heng Tan

DOI: https://doi.org/10.1016/j.ejmech.2014.11.021

IF: 7.088

2015-01-01

European Journal of Medicinal Chemistry

Abstract:G-Quadruplex nucleic acids or G-quadruplexes (G4s) are four-stranded DNA or RNA secondary structures that are formed in guanine-rich sequences. They are widely distributed in functional regions of the human genome, such as telomeres, ribosomal DNA (rDNA), transcription start sites, promoter regions and untranslated regions of mRNA, suggesting that G-quadruplex structures may play a pivotal role in the control of a variety of cellular processes. G-Quadruplexes are viewed as valid therapeutic targets in human cancer diseases. Small molecules, from naturally occurring to synthetic, are exploited to specifically target G-quadruplexes and have proven to be a new class of anticancer agents. Notably, alkaloids are an important source of G-quadruplex ligands and have significant bioactivities in anticancer therapy. In this review, the authors provide a brief, up-to-date summary of heterocyclic alkaloids and their derivatives targeting G-quadruplexes.
Targeting G-quadruplex Nucleic Acids with Heterocyclic Alkaloids and Their Derivatives

Ye Xiong,Zhi‐Shu Huang,Jia‐Heng Tan

DOI: https://doi.org/10.1016/j.ejmech.2014.11.021

IF: 7.088

2015-01-01

European Journal of Medicinal Chemistry

Abstract:G-Quadruplex nucleic acids or G-quadruplexes (G4s) are four-stranded DNA or RNA secondary structures that are formed in guanine-rich sequences. They are widely distributed in functional regions of the human genome, such as telomeres, ribosomal DNA (rDNA), transcription start sites, promoter regions and untranslated regions of mRNA, suggesting that G-quadruplex structures may play a pivotal role in the control of a variety of cellular processes. G-Quadruplexes are viewed as valid therapeutic targets in human cancer diseases. Small molecules, from naturally occurring to synthetic, are exploited to specifically target G-quadruplexes and have proven to be a new class of anticancer agents. Notably, alkaloids are an important source of G-quadruplex ligands and have significant bioactivities in anticancer therapy. In this review, the authors provide a brief, up-to-date summary of heterocyclic alkaloids and their derivatives targeting G-quadruplexes.
Developing Novel G-Quadruplex Ligands: from Interaction with Nucleic Acids to Interfering with Nucleic Acid–Protein Interaction

Zhi-Yin Sun,Xiao-Na Wang,Sui-Qi Cheng,Xiao-Xuan Su,Tian-Miao Ou

DOI: https://doi.org/10.3390/molecules24030396

2019-01-01

Abstract:G-quadruplex is a special secondary structure of nucleic acids in guanine-rich sequences of genome. G-quadruplexes have been proved to be involved in the regulation of replication, DNA damage repair, and transcription and translation of oncogenes or other cancer-related genes. Therefore, targeting G-quadruplexes has become a novel promising anti-tumor strategy. Different kinds of small molecules targeting the G-quadruplexes have been designed, synthesized, and identified as potential anti-tumor agents, including molecules directly bind to the G-quadruplex and molecules interfering with the binding between the G-quadruplex structures and related binding proteins. This review will explore the feasibility of G-quadruplex ligands acting as anti-tumor drugs, from basis to application. Meanwhile, since helicase is the most well-defined G-quadruplex-related protein, the most extensive research on the relationship between helicase and G-quadruplexes, and its meaning in drug design, is emphasized.
G-quadruplex DNA selective targeting for anticancer therapy: a computational study of a novel PtII monofunctional complex activated by adaptive binding.

Daniele Belletto,Fortuna Ponte,Nicole Sanna,Stefano Scoditti,E. Sicilia

DOI: https://doi.org/10.1039/d3dt02678g

IF: 4

2023-09-18

Dalton Transactions

Abstract:Targeting of G-quadruplex (G-Q) nucleic acids, which are helical four-stranded structures formed from guanine-rich nucleic acid sequences, has emerged in recent years as an appealing opportunity for drug intervention in anticancer therapy. Small-molecule drugs can stabilize quadruplex structures, promoting selective downregulation of gene expression and telomerase inhibition and also activating DNA damage responses. Thus, rational design of small molecular ligands able to selectively interact with and stabilize G-Q structures is a promising strategy for developing potent anti-cancer drugs with selective toxicity towards cancer cells over normal ones. Here, the outcomes of a thorough computational investigation of a recently synthesized monofunctional PtII complex (Pt1), whose selectivity for G-Q is activated by what is called adaptive binding, are reported. Quantum mechanics and molecular dynamics calculations have been employed for studying the classical key steps of the mechanism of action of PtII complexes, the conversion of the non-charged and non-planar Pt1 complex into a planar and charged PtII (Pt2) complex able to play the role of a G-Q binder and, finally, the interaction of Pt2 with G-Q. The information obtained from such an investigation allows us to rationalize the behavior of the novel PtII complex proposed to be activated by adaptive binding toward selective interaction with G-Q or similar molecules and can be exploited for designing ligands with more effective recognition ability toward G-quadruplex DNA.

Chemistry,Medicine
General Cell-Binding Activity of Intramolecular G-Quadruplexes with Parallel Structure

Tianjun Chang,Cui Qi,Jie Meng,Nan Zhang,Tao Bing,Xianda Yang,Zehui Cao,Dihua Shangguan

DOI: https://doi.org/10.1371/journal.pone.0062348

IF: 3.7

2013-04-26

PLoS ONE

Abstract:G-quadruplexes (G4s) are four-stranded nucleic acid structures adopted by some repetitive guanine-rich sequences. Putative G-quadruplex-forming sequences (PQSs) are highly prevalent in human genome. Recently some G4s have been reported to have cancer-selective antiproliferative activity. A G4 DNA, AS1411, is currently in phase II clinical trials as an anticancer agent, which is reported to bind tumor cells by targeting surface nucleolin. AS1411 also has been extensively investigated as a target-recognition element for cancer cell specific drug delivery or cancer cell imaging. Here we show that, in addition to AS1411, intramolecular G4s with parallel structure (including PQSs in genes) have general binding activity to many cell lines with different affinity. The binding of these G4s compete with each other, and their targets are certain cellular surface proteins. The tested G4s exhibit enhanced cellular uptake than non-G4 sequences. This uptake may be through the endosome/lysosome pathway, but it is independent of cellular binding of the G4s. The tested G4s also show selective antiproliferative activity that is independent of their cellular binding. Our findings provide new insight into the molecular recognition of G4s by cells; offer new clues for understanding the functions of G4s in vivo, and may extend the potential applications of G4s.

multidisciplinary sciences
Therapeutic Use of G4-Ligands in Cancer: State-of-the-Art and Future Perspectives

Sara Iachettini,Annamaria Biroccio,Pasquale Zizza

DOI: https://doi.org/10.3390/ph17060771

IF: 4.6

2024-06-14

Pharmaceuticals

Abstract:G-quadruplexes (G4s) are guanine-rich non-canonical secondary structures of nucleic acids that were identified in vitro almost half a century ago. Starting from the early 1980s, these structures were also observed in eukaryotic cells, first at the telomeric level and later in regulatory regions of cancer-related genes, in regulatory RNAs and within specific cell compartments such as lysosomes, mitochondria, and ribosomes. Because of the involvement of these structures in a large number of biological processes and in the pathogenesis of several diseases, including cancer, the interest in G4 targeting has exponentially increased in the last few years, and a great number of novel G4 ligands have been developed. Notably, G4 ligands represent a large family of heterogeneous molecules that can exert their functions by recognizing, binding, and stabilizing G4 structures in multiple ways. Regarding anti-cancer activity, the efficacy of G4 ligands was originally attributed to the capability of these molecules to inhibit the activity of telomerase, an enzyme that elongates telomeres and promotes endless replication in cancer cells. Thereafter, novel mechanisms through which G4 ligands exert their antitumoral activities have been defined, including the induction of DNA damage, control of gene expression, and regulation of metabolic pathways, among others. Here, we provided a perspective on the structure and function of G4 ligands with particular emphasis on their potential role as antitumoral agents. In particular, we critically examined the problems associated with the clinical translation of these molecules, trying to highlight the main aspects that should be taken into account during the phases of drug design and development. Indeed, taking advantage of the successes and failures, and the more recent technological progresses in the field, it would be possible to hypothesize the development of these molecules in the future that would represent a valid option for those cancers still missing effective therapies.

pharmacology & pharmacy,chemistry, medicinal
Natural Alkaloids And Heterocycles As G-Quadruplex Ligands And Potential Anticancer Agents

Tong Che,Yu-Qing Wang,Zhou-Li Huang,Jia-Heng Tan,Zhi-Shu Huang,Shuo-Bin Chen

DOI: https://doi.org/10.3390/molecules23020493

IF: 4.6

2018-01-01

Molecules

Abstract:G-quadruplexes are four-stranded nucleic acid secondary structures that are formed in guanine-rich sequences. G-quadruplexes are widely distributed in functional regions of the human genome and transcriptome, such as human telomeres, oncogene promoter regions, replication initiation sites, and untranslated regions. Many G-quadruplex-forming sequences are found to be associated with cancer, and thus, these non-canonical nucleic acid structures are considered to be attractive molecular targets for cancer therapeutics with novel mechanisms of action. In this mini review, we summarize recent advances made by our lab in the study of G-quadruplex-targeted natural alkaloids and their derivatives toward the development of potential anticancer agents.
Structurally diverse G-quadruplexes as the noncanonical nucleic acid drug target for live cell imaging and antibacterial study

Bo-Xin Zheng,Jie Yu,Wei Long,Ka Hin Chan,Alan Siu-Lun Leung,Wing-Leung Wong

DOI: https://doi.org/10.1039/d2cc05945b

2023-02-02

Abstract:The formation of G-quadruplex structures (G4s) in vitro from guanine (G)-rich nucleic acid sequences of DNA and RNA stabilized with monovalent cations, typically K+ and Na+, under physiological conditions, has been verified experimentally and some of them have high-resolution NMR or X-ray crystal structures; however, the biofunction of these special noncanonical secondary structures of nucleic acids has not been fully understood and their existence in vivo is still controversial at present. It is generally believed that the folding and unfolding of G4s in vivo is a transient process. Accumulating evidence has shown that G4s may play a role in the regulation of certain important cellular functions including telomere maintenance, replication, transcription and translation. Therefore, both DNA and RNA G4s of human cancer hallmark genes are recognized as the potential anticancer drug target for the investigation in cancer biology, chemical biology and drug discovery. The relationship between the sequence, structure and stability of G4s, the interaction of G4s with small molecules, and insights into the rational design of G4-selective binding ligands have been intensively studied over the decade. At present, some G4-ligands have achieved a new milestone and successfully entered the human clinical trials for anticancer therapy. Over the past few decades, numerous efforts have been devoted to anticancer therapy; however, G4s for molecular recognition and live cell imaging and for application as antibacterial agents and antibiofilms against antibiotic resistance have been obviously underexplored. The recent advances in G4-ligands in these areas are thus selected and discussed concentratedly in this article in order to shed light on the emerging role of G4s in chemical biology and therapeutic prospects against bacterial infections. In addition, the recently published molecular scaffolds for designing small ligands selectively targeting G4s in live cell imaging, bacterial biofilm imaging, and antibacterial studies are discussed. Furthermore, a number of underexplored G4-targets from the cytoplasmic membrane-associated DNA, the conserved promoter region of K. pneumoniae genomes, the RNA G4-sites in the transcriptome of E. coli and P. aeruginosa, and the mRNA G4-sites in the sequence for coding the vital bacterial FtsZ protein are highlighted to further explore in G4-drug development against human diseases.
Structural requirement of G-quadruplex/aptamer-combined DNA macromolecule serving as efficient drug carrier for cancer-targeted drug delivery

Congcong Li,Biting Wu,Si Chen,Kaixuan Hao,Jie Yang,Hongwen Cao,Shulin Yang,Zai-Sheng Wu,Zhifa Shen

DOI: https://doi.org/10.1016/j.ejpb.2020.11.021

IF: 5.589

2021-02-01

European Journal of Pharmaceutics and Biopharmaceutics

Abstract:<p>Photodynamic therapy (PDT) as a clinical cancer treatment method has been used to treat carcinomas in different organs, and G-quadruplex-based DNA nanocompartments serving as the carriers of cationic porphyrin photosensitizers, especially combined with cell-targeting aptamers, is considered to offer new opportunities for future cancer treatment. However, the structural features of G-quadruplex/aptamer complexes suitable for the capsulation of photosensitizers and target cell recognition is unexplored so far. In this study, unimolecular (UM), bimolecular (BM) and tetramolecular (TM) G-quadruplex structures were used as the drug loading compartments and grafted onto tumor cell-targeting aptamer Sgc8, constructing several targeting drug delivery vehicles (T-GMVs). Besides the binding affinity of resulting DNA architectures for target cells and cell recognition specificity were explored in a comparative fashion, the drug loading capability and cancer therapy efficacy were evaluated using TMPyP4 as the model porphyrin-based drug. The experimental results show that only TM G-quadruplex structure is suitable to combine with Sgc8 for the development of drug delivery vehicle and the as-prepared T-GMV- TMPyP4 complexes display the desirable cancer therapy efficacy, holding the potential application in the future cancer therapy. More importantly, T-GMV- TMPyP4 is expected to lay the scientific groundwork for the successful development of G-quadruplex-based photosensitizer drug delivery carriers for the targeted cancer therapy.</p>

pharmacology & pharmacy
G-Quadruplex-Binding Proteins: Promising Targets for Drug Design

Huiling Shu,Rongxin Zhang,Ke Xiao,Jing Yang,Xiao Sun

DOI: https://doi.org/10.3390/biom12050648

IF: 6.064

2022-04-29

Biomolecules

Abstract:G-quadruplexes (G4s) are non-canonical secondary nucleic acid structures. Sequences with the potential to form G4s are abundant in regulatory regions of the genome including telomeres, promoters and 5′ non-coding regions, indicating they fulfill important genome regulatory functions. Generally, G4s perform various biological functions by interacting with proteins. In recent years, an increasing number of G-quadruplex-binding proteins have been identified with biochemical experiments. G4-binding proteins are involved in vital cellular processes such as telomere maintenance, DNA replication, gene transcription, mRNA processing. Therefore, G4-binding proteins are also associated with various human diseases. An intensive study of G4-protein interactions provides an attractive approach for potential therapeutics and these proteins can be considered as drug targets for novel medical treatment. In this review, we present biological functions and structural properties of G4-binding proteins, and discuss how to exploit G4-protein interactions to develop new therapeutic targets.

biochemistry & molecular biology
The New Anticancer Platinum Complex Designed on the Basis of Nucleic Acid

Zheng Xiaohui,Xia Lixin,Mao Zongwan

DOI: https://doi.org/10.7536/pc160112

2016-01-01

Progress in chemistry

Abstract:Tumor is one of the serious diseases which greatly threaten human's health. Therefore, the large amount of innovative anticancer drugs have been discovered and created. Among these anticancer drugs, cis platinum and its analogs are some of the most effective chemotherapeutic agents in clinical use, particularly in the treatment of testicular and ovarian cancers. Unfortunately, they have several major drawbacks, such as cumulative toxicities of nephrotoxicity and ototoxicity, inherent or treatment-induced resistance. This has provided the urgency and motivation for developing novel platinum complexes with high antitumor effect and low toxic side effect on normal cells. This review highlights some methods on the development of the novel platinum complexes: (1) developing the platinum complex with new structure, like trans-platinum complex, multinuclear platinum complex, Pt( IV) complex; (2) developing new anticancer target, such as G-quadruplex (G4) DNA. By consideration of the anticancer mechanism of the drugs and the tolerance of cis-platinum, the prospect provides new ways to develop novel platinum complexes with high antitumor effect and low toxic side effect on normal cells. This review highlights recent progress of the platinum complexes as anticancer drugs and discuss their future potential in the medical fields.
A G-quadruplex-binding platinum complex induces cancer mitochondrial dysfunction in vitro and in vivo independently of ROS induction

Tao JIA,Keli Kuang,Chunyan Li,Fatlinda Maksut,Deepanjan Ghosh,Robin Vinck,Maoling Wang,Joël Poupon,Run Xiang,Wen Li,Fei Li,Zhu Wang,Junrong Du,Marie-Paule Teulade-Fichou,Gilles Gasser,Sophie Bombard

DOI: https://doi.org/10.26434/chemrxiv-2023-npl8r

2023-11-16

Abstract:G-quadruplex DNA (G4) is a non-canonical structure forming in guanine-rich regions, which play a vital role in cancer biology and are now being acknowledged in both nuclear and mitochondrial (mt) genome. However, the impact of G4-based targeted therapy on both nuclear and mt genome, affecting mt function and its underlying mechanisms remain largely unexplored. Here, we first demonstrated that the G4-binding platinum(II) complex, Pt-ttpy, shows a highest accumulation in the mitochondria of A2780 cancer cells as compared with two other platinum(II) complexes with no/weak G4-binding properties, Pt-tpy and cisplatin. Pt-ttpy significantly induces deletion, copy number reduction and transcription inhibition of mt DNA, and it hinders the translation of mt proteins. Functional study shows that Pt-ttpy induces a potent mt dysfunction indicated by a high reduction of mt membrane potential, oxygen consumption rate and ATP synthesis, as well as toxic mt morphology switching, but without reactive oxygen species (ROS) induction. Mechanistic study by RNA-seq, Chip-seq and CUT-RUN shows Pt-ttpy impairs most nuclear-encoded mt ribosome genes’ transcription initiation through dampening the recruiting of TAF1 and NELFB to their promoter, which are highly enriched in G4 forming sequences. In vivo studies on a A2780 tumor xenograft mouse model suggest Pt-ttpy’s efficient anti-tumor effects, causing substantial disruption in mt genome function, while exhibiting less side effects compared to cisplatin. Overall, this study presents the first evidence that a G4-binding platinum(II) complex can harm cancer cell mitochondria potently without inducing ROS activity, potentially reducing side effects that shows promise in developing safer and effective platinum-based G4-binding molecules in cancer therapy.

Chemistry
Natural products and their derivatives as G-quadruplex binding ligands

Chan Shan,Jia-Heng Tan,Tian-Miao Ou,Zhi-Shu Huang

DOI: https://doi.org/10.1007/s11426-013-4920-y

2013-01-01

Science China Chemistry

Abstract:G-quadruplexes comprise a class of secondary structures that are formed in guanine-rich sequences in eukaryotic genomes and play a crucial role in the regulation of many biological events. G-quadruplexes have become targets for anticancer drugs with high selectivity vs. duplex DNA and low cytotoxicity against normal cells. Natural products and their derivatives display polymorphism, structural complexity, and potent activity. It is, therefore, reasonable to seek ligands targeting G-quadruplexes from natural products. Recently, many successful examples have been reported, showing ligands with excellent anticancer activities. In this review, we summarized the development of research on natural products and derivatives that target G-quadruplex structures in an effort to guide future studies.

G-quadruplex DNA Targeted Metal Complexes Acting As Potential Anticancer Drugs

G-quadruplex ligands in cancer therapy: Progress, challenges, and clinical perspectives

Interaction of Metal Complexes with G-quadruplex

Design of Selective G-quadruplex Ligands As Potential Anticancer Agents

G-quadruplexes: targets in anticancer drug design.

G-Quadruplex-Guided Cisplatin Triggers Multiple Pathways in Targeted Chemotherapy and Immunotherapy

G-quadruplex stabilization via small-molecules as a potential anti-cancer strategy

G-quadruplexes: a promising target for cancer therapy

Targeting G-quadruplex nucleic acids with heterocyclic alkaloids and their derivatives.

Targeting G-quadruplex Nucleic Acids with Heterocyclic Alkaloids and Their Derivatives

Developing Novel G-Quadruplex Ligands: from Interaction with Nucleic Acids to Interfering with Nucleic Acid–Protein Interaction

G-quadruplex DNA selective targeting for anticancer therapy: a computational study of a novel PtII monofunctional complex activated by adaptive binding.

General Cell-Binding Activity of Intramolecular G-Quadruplexes with Parallel Structure

Therapeutic Use of G4-Ligands in Cancer: State-of-the-Art and Future Perspectives

Natural Alkaloids And Heterocycles As G-Quadruplex Ligands And Potential Anticancer Agents

Structurally diverse G-quadruplexes as the noncanonical nucleic acid drug target for live cell imaging and antibacterial study

Structural requirement of G-quadruplex/aptamer-combined DNA macromolecule serving as efficient drug carrier for cancer-targeted drug delivery

G-Quadruplex-Binding Proteins: Promising Targets for Drug Design

The New Anticancer Platinum Complex Designed on the Basis of Nucleic Acid

A G-quadruplex-binding platinum complex induces cancer mitochondrial dysfunction in vitro and in vivo independently of ROS induction

Natural products and their derivatives as G-quadruplex binding ligands